Clinical Trials Directory

Trials / Completed

CompletedNCT03135431

Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery

Opportunistic Salpingectomy at the Time of Cesarean Delivery: A Randomized Controlled Trial of the Safety of Salpingectomy vs Tubal Ligation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety of performing a bilateral tubal ligation vs. bilateral salpingectomy, two procedures performed for permanent sterilization, at the time of cesarean delivery. The investigators want to determine if performing bilateral salpingectomy at the time of cesarean delivery poses any greater risk for blood loss, as compared to a bilateral tubal ligation.

Detailed description

A non-inferiority, two-arm randomized controlled trial to evaluate the safety and feasibility of prophylactic salpingectomy at the time of a cesarean delivery will be conducted as an initiative to avoid a missed opportunity in the primary prevention of ovarian cancer. Once enrolled and consented, women will be randomized using a stratified block randomization algorithm according to number of prior cesarean deliveries and BMI to either salpingectomy or bilateral tubal ligation. The data collection will include preoperative CBC, time of procedure, postoperative CBC at 24 hours, standard patient demographics, procedural complications, estimated blood loss, return to the OR, length of stay, pain scores, and postoperative complications, including readmission within 6 weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREBilateral SalpingectomySurgical removal of entire fallopian tubes
PROCEDUREBilateral Tubal LigationSurgical tying, cutting, or removal of a portion of the fallopian tubes

Timeline

Start date
2017-05-17
Primary completion
2018-05-19
Completion
2018-07-30
First posted
2017-05-01
Last updated
2019-07-10
Results posted
2019-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03135431. Inclusion in this directory is not an endorsement.